Early Detection and Interception of Cancer: Current Practice Recommendations and Novel Emerging Approaches
- Continuing Education
Elevate your approach to cancer prevention with this dynamic course offering practical guidance on current screening practices, management of high-risk populations, and the integration of emerging early detection technologies into clinical care.
- Live Online or In Person
Participants may attend either virtually or in person.
Joseph B. Martin Conference Center, 77 Avenue Louis Pasteur, Boston, MA 02115
Continuing Education Credits
2025 Accreditation information is listed below, 2026 will be announced soon.
On This Page
Overview
Through this course we will provide a comprehensive review of current cancer screening guidelines, provide guidance regarding high-risk populations and their management, educate regarding emerging technologies for early cancer detection, and provide referral pathways for complex patients.
Learning Objectives
- Identify and implement current cancer screening guidelines, with a focus on early detection and intervention for high-risk populations, and provide recommendations for managing these patients.
- Identify and establish appropriate referral pathways for patients with pre-malignant conditions requiring specialized care.
- Evaluate emerging technologies in cancer detection and assess their application for early detection of cancer.
Developed and Offered By:
Continuing Education courses are developed by faculty from Harvard Medical School's teaching hospitals and accredited by Harvard Medical School. This course is offered by Dana-Farber Cancer Institute.
Participant Types
Schedule
All agenda sessions are in Eastern Time.
Monday, September 15, 2025
Welcome and Kick Off
9:00-9:15 am
Whole Body Imaging for Screening and Early Detection of Cancer – Promises and Pitfalls
9:15-9:45 am
Management of DCIS (Ductal Carcinoma in SITU) and Other Breast Cancer Precursors
9:45-10:00 am
Genetics 101: Identification and Genetic Testing for Inherited Cancer Predisposition
10:00-10:15 am
Management of Hereditary Cancer Predisposition in Your Practice
10:15-10:30 am
Screening and Early Detection of Gynecologic Malignancies
10:30-10:45 am
Q&A
10:45-11:00 am
Break
11:00-11:15 am
Screening and Early Detection of Dermatologic Malignancies
11:15-11:30 am
Unexplained Cytopenia - When to Consider Clonal Hematopoiesis and Myelodysplastic Syndrome (MDS)
11:30-11:45 am
Intercepting Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma
11:45 am-12:00 pm
Q&A
12:00-12:15 pm
Lunch Break
12:15-1:00 pm
Precursors to Head & Neck, Oral Cancers, and Management
1:00-1:15 pm
Management of IPMNs, Barrett's Esophagus and other Precursors to GI Cancer
1:15-1:30 pm
Screening and Early Detection of Lung Cancer
1:30-1:45 pm
Screening and Early Detection of Genitourinary Cancers
1:45-2:00 pm
Q&A
2:00-2:15 pm
Break
2:15-2:30 pm
Multi-Cancer Early Detection Tests – Ready for Prime Time?
2:30-2:45 pm
Promoting Equity in Screening and Early Detection
2:45-3:00 pm
Patient Experience with Multi-Cancer Early Detection Testing
3:00-3:15 pm
Panel Discussion: Looking to the Future of Early Detection and Interception
3:15-3:30 pm
Networking Reception
3:30-4:30 pm
Faculty
Harvard Medical School Continuing Education attracts the best and brightest faculty from all around the world. As a student in this course, you’ll have access to outstanding course directors and faculty.
Elizabeth (Betsy) O’Donnell, MD
Course Director
- Director, Multi-Cancer Early Detection Clinic, Dana-Farber Cancer Institute
- Assistant Professor of Medicine, Harvard Medical School
Sapna Syngal, MD, MPH
Course Director
- Director, Centers for Early Detection and Interception, Solid Tumors, Dana-Farber Cancer Institute
- Director of Research, Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute
- Professor of Medicine, Harvard Medical School
Benjamin L. Ebert, MD, PhD
President & CEO of Dana-Farber Cancer Institute
Director of Dana-Farber/Harvard Cancer Center
Richard and Susan Smith Professor of Medicine, Harvard Medical School
Colleen Feltmate, MD
Co-Director, Center for Early Detection and Interception, Gynecologic Tumors, Dana-Farber Cancer Institute
Director, Minimally Invasive Surgery in Gynecologic Oncology, Brigham and Women's Hospital
Assistant Professor of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School
Irene Ghobrial, MD
Senior Vice President for Experimental Medicine, Dana-Farber Cancer Institute
Director of the Center for Early Detection and Interception of Blood Cancers, Dana-Farber Cancer Institute
Professor of Medicine, Harvard Medical School
Glenn Hanna, MD
Director, Center for Cancer Therapeutic Innovation (Early Drug Development Program), Dana-Farber Cancer Institute
Director, Center for Salivary and Rare Head and Neck Cancers, Dana-Farber Cancer Institute
Associate Professor of Medicine, Harvard Medical School
Elizabeth Kearns, MS, LGC
Genetic Counselor, Cancer Genetics and Prevention, Dana-Farber Cancer Institute
Nicole Leboeuf, MD, MPH
Vice Chair, Department of Dermatology, Dana-Farber Cancer Institute
Director, Cutaneous Oncology, Dana-Farber Cancer Institute
Associate Professor of Dermatology, Harvard Medical School
Huma Rana, MD, MPH
Clinical Director, Cancer Genetics and Prevention, Dana-Farber Cancer Institute
Assistant Professor of Medicine, Harvard Medical School
Timothy Rebbeck, PhD
Vincent L. Gregory, Jr. Professor of Cancer Prevention, Harvard TH Chan School of Public Health and Dana-Farber Cancer Institute
Director, Zhu Family Center for Global Cancer Prevention, Harvard TH Chan School of Public Health
Researcher, Division of Population Sciences, Dana-Farber Cancer Institute
Nicolette Rodriguez, MD, MPH
Director, Center for Early Detection and Interception, Gastrointestinal Tumors, Dana-Farber Cancer Institute
Instructor in Medicine, Harvard Medical School
Michael Rosenthal, MD, PhD
Assistant Director of Radiology, Dana-Farber/Brigham and Women's Hospital Pancreas and Biliary Tumor Center
Assistant Professor of Radiology, Harvard Medical School
Jacob Sands, MD
Associate Chief, Thoracic Oncology, Dana-Farber Cancer Institute
Assistant Professor, Harvard Medical School
Emily Stern Gatof, MD
Oncologist, Breast Oncology and Cancer Genetics and High Risk, Cancer Center at Beth Israel Deaconess Medical Center
Instructor of Clinical Medicine, Harvard Medical School
Dr. Bicky Thapa, MD, MS, FACP
Director, Center for Early Detection and Interception, Genitourinary Tumors, Dana-Farber Cancer Institute
Instructor in Medicine, Harvard Medical School
Lachelle Weeks, MD, PhD
Director, Center for Early Detection and Interception, CHIP, Dana-Farber Cancer Institute
Assistant Professor of Medicine, Harvard Medical School
Karen Burns White
Deputy Associate Director, Initiative to Eliminate Cancer Disparities, Dana-Farber/Harvard Cancer Center
Location Information
Venue
All in person sessions will be held at:
Joseph B. Martin Conference Center
77 Avenue Louis Pasteur
Boston, MA 02115
Learners are also invited to attend virtually.
Hotel Reservations
Hotel Commonwealth
500 Commonwealth Avenue
Boston, MA 02215
www.hotelcommonwealth.com
Sean.Minnihan@hotelcommonwealth.com
Request Information
Interested in learning more about this program? Sign up for details.
Course Fees
Fee Disclaimer
You may register through our secure online environment and will receive an email confirmation upon receipt of your payment.
Prices include CME credit, electronic syllabus, and refreshments at breaks and breakfast.
At the end of the registration process, a $10 non-refundable processing fee will be added to your registration.
| Role | Course Fee |
|---|---|
| Physician (MD/DO) | $500.00 |
| Nurse (RN/APRN) | $250.00 |
| PA | $250.00 |
| Psychologist | $250.00 |
| Resident/Fellow | Free |
| Social Worker | $250.00 |
| Allied Health Professional / Other | $250.00 |
Accreditation
The Harvard Medical School designates this live activity for a maximum of 5.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Harvard Medical School designates this live activity for a maximum of 5.00 ANCC contact hours.
Harvard Medical School has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS). Additional information regarding this agreement may be found on the European Union of Medical Specialties website.
The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.